<SEC-DOCUMENT>0001562180-25-000917-index.html : 20250204
<SEC-HEADER>0001562180-25-000917.hdr.sgml : 20250204
<ACCEPTANCE-DATETIME>20250204175418
ACCESSION NUMBER:		0001562180-25-000917
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20250131
FILED AS OF DATE:		20250204
DATE AS OF CHANGE:		20250204

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Butler John P.
		CENTRAL INDEX KEY:			0001591467
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36352
		FILM NUMBER:		25589935

	MAIL ADDRESS:	
		STREET 1:		C/O RELYPSA, INC.
		STREET 2:		700 SAGINAW DR.
		CITY:			REDWOOD CITY
		STATE:			CA
		ZIP:			94063

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Akebia Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001517022
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				208756903
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		245 FIRST STREET
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142
		BUSINESS PHONE:		617-871-2098

	MAIL ADDRESS:	
		STREET 1:		245 FIRST STREET
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>primarydocument.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
Document 1 - file: primarydocument.html

Document 1 - RAW XML: primarydocument.xml

</DOCUMENT>
</SEC-DOCUMENT>